Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases
Over the past decade, there has been increasing attention on the interaction between microbiota and bile acid metabolism. Bile acids are not only involved in the metabolism of nutrients, but are also important in signal transduction for the regulation of host physiological activities. Microbial-regulated bile acid metabolism has been proven to affect many diseases, but there have not been many studies of disease regulation by microbial receptor signaling pathways. This review considers findings of recent research on the core roles of farnesoid X receptor (FXR), G protein-coupled bile acid receptor (TGR5), and vitamin D receptor (VDR) signaling pathways in microbial–host interactions in health and disease. Studying the relationship between these pathways can help us understand the pathogenesis of human diseases, and lead to new solutions for their treatments.
Key wordsGut microbiota Bile acid Farnesoid X receptor Vitamin D receptor Metabolism
近十年来, 微生物与胆汁酸代谢的相互作用越来越受到关注。 胆汁酸不仅参与营养物质的代谢, 而且在调节宿主生理活动的信号转导中也起着重要作用。 已有研究表明, 微生物调控的胆汁酸代谢对许多疾病都有显著的影响, 但对微生物受体信号通路调控疾病的相关研究并不多。 本文综述了近年来有关法尼醇受体 (FXR)、 G 蛋白偶联胆汁酸受体 (TGR5) 和维生素 D 受体 (VDR) 信号通路在健康和疾病的微生物-宿主相互作用中的核心作用。 研究这些信号通路之间的关系, 有助于我们了解人类疾病的发病机制, 为人类疾病的治疗提供新的解决方案。
关键词肠道微生物群 胆汁酸 法尼醇受体 维生素 D 受体 代谢
Unable to display preview. Download preview PDF.
Er-teng JIA and Qin-yu GE designed the research. Er-teng JIA wrote the manuscript. Zhi-yu LIU, Min PAN, Jia-feng LU, and Qin-yu GE provided guidance on the writ¬ing of this review. All authors read and approved the final manuscript.
Compliance with ethics guidelines
Er-teng JIA, Zhi-yu LIU, Min PAN, Jia-feng LU, and Qin-yu GE declare that they have no conflict of interest.
This article does not contain any studies with human or animal subjects performed by any of the authors.
- Cariello M, Piccinin E, Garcia-Irigoyen O, et al., 2017. Nuclear receptor FXR, bile acids and liver damage: introducing the progressive familial intrahepatic cholestasis with FXR mutations. Biochim Biophys Acta Mol Basis Dis, 1864(4): 1308–1318. https://doi.org/10.1016/j.bbadis.2017.09.019 CrossRefGoogle Scholar
- Masubuchi N, Sugihara M, Sugita T, et al., 2016. Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: promising diagnostic biomarkers for cholestasis. Chem Biol Interact, 255:83–91. https://doi.org/10.1016/j.cbi.2015.08.016 CrossRefGoogle Scholar
- Russell DW, 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem, 72:137–174. https://doi.org/10.1146/annurev.biochem.72.121801.161712 CrossRefGoogle Scholar
- Theriot CM, Bowman AA, Young VB, 2016. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere, 1(1):e00045-15. https://doi.org/10.1128/mSphere.00045-15
- Vijayvargiya P, Camilleri M, Carlson P, et al., 2017. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther, 46(6):581–588. https://doi.org/10.1111/apt.14214 CrossRefGoogle Scholar
- Wang YD, Chen WD, Yu D, et al., 2011. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology, 54(4):1421–1432. https://doi.org/10.1002/hep.24525 CrossRefGoogle Scholar